TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A(Homo sapiens (Human))
Intra-Cellular Therapies
US Patent
Intra-Cellular Therapies
US Patent
Affinity DataKi: 0.100nM ΔG°: -58.0kJ/molepH: 7.5 T: 2°CAssay Description:Materials: All chemicals are available from Sigma-Aldrich (St. Louis, Mo.) except for IMAP reagents (reaction buffer, binding buffer, FL-GMP and IMAP...More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A(Homo sapiens (Human))
Intra-Cellular Therapies
US Patent
Intra-Cellular Therapies
US Patent
Affinity DataKi: 0.200nM ΔG°: -56.3kJ/molepH: 7.5 T: 2°CAssay Description:Materials: All chemicals are available from Sigma-Aldrich (St. Louis, Mo.) except for IMAP reagents (reaction buffer, binding buffer, FL-GMP and IMAP...More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A(Homo sapiens (Human))
Intra-Cellular Therapies
US Patent
Intra-Cellular Therapies
US Patent
Affinity DataKi: 0.300nM ΔG°: -55.3kJ/molepH: 7.5 T: 2°CAssay Description:Materials: All chemicals are available from Sigma-Aldrich (St. Louis, Mo.) except for IMAP reagents (reaction buffer, binding buffer, FL-GMP and IMAP...More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A(Homo sapiens (Human))
Intra-Cellular Therapies
US Patent
Intra-Cellular Therapies
US Patent
Affinity DataKi: 0.400nM ΔG°: -54.5kJ/molepH: 7.5 T: 2°CAssay Description:Materials: All chemicals are available from Sigma-Aldrich (St. Louis, Mo.) except for IMAP reagents (reaction buffer, binding buffer, FL-GMP and IMAP...More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A(Homo sapiens (Human))
Intra-Cellular Therapies
US Patent
Intra-Cellular Therapies
US Patent
Affinity DataKi: 0.5nM ΔG°: -54.0kJ/molepH: 7.5 T: 2°CAssay Description:Materials: All chemicals are available from Sigma-Aldrich (St. Louis, Mo.) except for IMAP reagents (reaction buffer, binding buffer, FL-GMP and IMAP...More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 0.540nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 0.890nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 0.940nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A(Homo sapiens (Human))
Intra-Cellular Therapies
US Patent
Intra-Cellular Therapies
US Patent
Affinity DataKi: 1nM ΔG°: -52.2kJ/molepH: 7.5 T: 2°CAssay Description:Materials: All chemicals are available from Sigma-Aldrich (St. Louis, Mo.) except for IMAP reagents (reaction buffer, binding buffer, FL-GMP and IMAP...More data for this Ligand-Target Pair
Affinity DataKi: 1nMAssay Description:Inhibition of histamine H1 receptor (unknown origin)More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 1nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 1.10nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 1.30nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 1.70nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Affinity DataKi: 2nMAssay Description:Inhibition of histamine H1 receptor (unknown origin)More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 2.10nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 2.40nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 2.5nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 2.5nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 2.90nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 3.30nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 3.5nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A(Homo sapiens (Human))
Intra-Cellular Therapies
US Patent
Intra-Cellular Therapies
US Patent
Affinity DataKi: 4nM ΔG°: -48.7kJ/molepH: 7.5 T: 2°CAssay Description:Materials: All chemicals are available from Sigma-Aldrich (St. Louis, Mo.) except for IMAP reagents (reaction buffer, binding buffer, FL-GMP and IMAP...More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A(Homo sapiens (Human))
Intra-Cellular Therapies
US Patent
Intra-Cellular Therapies
US Patent
Affinity DataKi: 4nM ΔG°: -48.7kJ/molepH: 7.5 T: 2°CAssay Description:Materials: All chemicals are available from Sigma-Aldrich (St. Louis, Mo.) except for IMAP reagents (reaction buffer, binding buffer, FL-GMP and IMAP...More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 4nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Intra-Cellular Therapies
US Patent
Intra-Cellular Therapies
US Patent
Affinity DataKi: 4.20nMAssay Description:Assay Type: BindingSpecies: HumanOrigin: Recombinant/CHO cellsLigand: [3H]-NisoxetineLigand [M]: 1.00E-09Kd (Binding Affinity): 3.00E-09Bmax: 10 pmol...More data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 4.60nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 4.70nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 4.70nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 5.20nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 5.5nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 5.70nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 5.80nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 7.10nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2C receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 7.5nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 7.70nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 9.60nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
TargetAlpha-1B adrenergic receptor(Rattus norvegicus (rat))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 12nMAssay Description:Inhibition of rat adrenergic alpha1B receptorMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 13nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2C receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 14nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 14nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 17nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 18nMAssay Description:Displacement of [125]DOI from human recombinant full length 5HT2A receptor expressed in HEK293E cellsMore data for this Ligand-Target Pair
Affinity DataKi: 19nMAssay Description:Inhibition of adrenergic alpha1A receptor (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 27nMAssay Description:Displacement of [3H]-N-methylspiperone from rat recombinant dopamine D2 short receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 27nMAssay Description:Displacement of [3H]-N-methylspiperone from rat recombinant dopamine D2 short receptor expressed in CHO cellsMore data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 27nMAssay Description:Displacement of [3H]-N-methyl-citalopram from SERT in human platelets after 60 mins by liquid scintillation counting analysisMore data for this Ligand-Target Pair
Affinity DataKi: 28nMAssay Description:Inhibition of human dopamine D4 receptorMore data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 28nMAssay Description:Displacement of [3H]-N-methyl-citalopram from SERT in human platelets after 60 mins by liquid scintillation counting analysisMore data for this Ligand-Target Pair
Affinity DataKi: 30nMAssay Description:Displacement of [3H]-N-methylspiperone from rat recombinant dopamine D2 short receptor expressed in CHO cellsMore data for this Ligand-Target Pair